GAFFX
Price
$67.61
Change
+$0.37 (+0.55%)
Updated
Apr 14 closing price
Net Assets
265.04B
STCIX
Price
$7.77
Change
+$0.14 (+1.83%)
Updated
Apr 11 closing price
Net Assets
193.07M
Ad is loading...

GAFFX vs STCIX

Header iconGAFFX vs STCIX Comparison
Open Charts GAFFX vs STCIXBanner chart's image
American Funds Growth Fund of Amer F3
Price$67.61
Change+$0.37 (+0.55%)
VolumeN/A
Net Assets265.04B
Virtus Silvant Large-Cap Growth Stk A
Price$7.77
Change+$0.14 (+1.83%)
VolumeN/A
Net Assets193.07M
GAFFX vs STCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. STCIX commentary
Apr 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a Buy and STCIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 265B vs. STCIX (193M). GAFFX pays higher dividends than STCIX: GAFFX (0.72) vs STCIX (0.00). GAFFX was incepted earlier than STCIX: GAFFX (8 years) vs STCIX (33 years). STCIX (1.26) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. STCIX (17.00). STCIX has a lower initial minimum investment than GAFFX: STCIX (2500) vs GAFFX (1000000). STCIX annual gain was more profitable for investors over the last year : 1.30 vs. GAFFX (-2.72). STCIX return over 5 years is better than : 57.93 vs. GAFFX (46.26).
GAFFXSTCIXGAFFX / STCIX
Total Expense Ratio0.301.0329%
Annual Report Gross Expense Ratio0.301.2624%
Fund Existence8 years33 years-
Gain YTD-9.212-11.70579%
Front LoadN/A6%-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets265B193M137,306%
Annual Yield % from dividends0.720.00-
Returns for 1 year-2.721.30-209%
Returns for 3 years7.9426.5530%
Returns for 5 years46.2657.9380%
Returns for 10 yearsN/A-12.89-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRIN14.150.59
+4.35%
Trinity Capital
LYRA0.11N/A
+4.01%
Lyra Therapeutics
XP13.730.27
+2.01%
XP
CNF0.67N/A
+0.69%
CNFinance Holdings Limited
IART16.73-0.26
-1.53%
Integra LifeSciences Holdings Corp